Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
August 30 2019 - 8:30AM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that management will present at the
following investor conferences in September:
- Wells Fargo 2019 Healthcare Conference Presentation
Date: Thursday, Sept 5th at 10:55 a.m. Eastern Time Location:
Boston, MA
- Morgan Stanley 17th Annual Global Healthcare Conference
Presentation Date: Monday, Sept 9th at 8:10 a.m. Eastern Time
Location: New York, NY
Presentations will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations. The presentation will also
be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, ex vivo gene-edited cell
therapy, and in vivo genome editing and gene regulation. For more
information about Sangamo, visit www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190830005134/en/
Investor Relations – Global McDavid
Stilwell 510-970-6000, x219 mstilwell@sangamo.com
Media Inquiries – Global Aron
Feingold 510-970-6000, x421 afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2023 to Sep 2024